Quick Answer
Heartflow, Inc. reported Cash and Equivalents of $44.78 million for fiscal year 2025.
Heartflow, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $44.78M | -12.8% |
| 2024 | $51.37M | -58.2% |
| 2023 | $122.77M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $291.17M | +350.3% | +263.0% |
| June 30, 2025 | $80.21M | +6.4% | +56.2% |
| December 31, 2024 | $51.37M | — | -20.6% |
| September 30, 2024 | $64.66M | — | -14.2% |
| June 30, 2024 | $75.37M | — | — |
- Heartflow, Inc. showed a decrease of -12.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2023–2025 period, Heartflow, Inc.’s cash and equivalents has declined by 63.5% (from $122.77 million to $44.78 million).
- The most recent figure is from Heartflow, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: